psychometric assessment: Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.
semi-structured clinical interview: Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)
Study summary
The investigators will study the prevalence of dissociative identity disorder (DID) in three populations at risk in cases of childhood psychotrauma : patients with a diagnosis of borderline personality, patients with a diagnosis of functional dissociative crises (FDC) and patients with early psychosis.
The investigators will also study the prevalence of other dissociative disorders and the frequency of complex post-traumatic stress disorder.
The investigators will also look for correlations between the type of maltreatment in childhood, the age of onset of trauma and the type of diagnosis of dissociative disorders.
The investigators hope to include 150 borderline patients, 150 FDC patients and 50 early psychosis patients.
Data collection will be done via a psychometric administration of 7 self-completion questionnaires as well as the completion of the SCID-D semi-structured interview.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
I - Inclusion Criteria:
I-1: For all groups:
* Male or female
* Age \> or = 18
* Enrolled in or benefiting from a social security scheme
* Patient fluent in French
* Patient willing to undergo a psychological evaluation between 1h30 and 3h30
* Patient with a known history of psychotrauma in childhood before the age of 18 (sexual abuse, mistreatment, school harassment, natural disasters, attacks, etc.).
* Patient having received and understood complete information on the organization of the research and having given written free and informed consent prior to participation in the study.
I-2 : Patients in the borderline group
* Patients with main diagnosis of emotionally labile personality
* Patients with at least one psychiatric hospitalization in the last 3 years
I-3 : Patients in the early psychosis group
Patient with a diagnosis of mental state at risk of psychosis according to the criteria defined by CAARMS (Comprehensive Assessment of At Risk Mental State) OR Patients diagnosed with a first psychotic episode on an outpatient basis or following a hospital stay
I-4 : Patients in the functional dissociative crises group
Patients diagnosed with functional dissociative crises by a specialized epileptologist
II- Non-inclusion criteria
* Impairment of the subject making it difficult or not impossible to participate in the trial or to understand the information provided to him/her
* Patients with specific difficulties in understanding SCID-D questions
* Psychiatric condition requiring hospitalization
* Patients with symptoms of recent toxic consumption (alcohol, cannabis, other ...) disrupting assessment responses
* Patient taking part in a pharmacological study involving a pro-dissociative molecule of the psychedelic type
* Pregnant, parturient or nursing mothers
* Person deprived of liberty by judicial or administrative decision
* Person in a life-threatening emergency
* An adult under legal protection (guardianship, curatorship, safeguard of justice)
* Person unable to give consent and not subject to a legal protection measure
Primary outcome measure(s)
SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders / DSM = Diagnostic and Statistical Manual of Mental Disorders / ICD = International Classification of Diseases — Inclusion visit assesses the dissociative identity disorder
Trial sites (3)
Facility
City
Region
Status
Centre Psychothérapique de Nancy - CLIP
Nancy
France
Not Yet Recruiting
Centre Psychothérapique de Nancy - CMP Jacquard et Des Près
Nancy
France
Recruiting
CHRU Nancy - Neurology department
Nancy
France
Recruiting
More Centre Psychothérapique de Nancy trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.